While these are the most recent statistics available, advances in a disease-modifying therapy (DMT) for MS may actually slow down the progression. However, it is too soon to tell by how much DMT ...

MS is a spectrum of diseases, //sometimes mimicking tumors (TMS) The Unseen Struggle That Demands Global Solidarity World ...

One theory that supports this is that a lack of sunlight and subsequently vitamin D plays a role in the development of MS. Worldwide, the median estimated prevalence of MS is 30 per 100,000 ...

Dr Conor Kerley–who has the disease himself– says there are several theories as to why the small island has such a ...

Multiple Sclerosis companies are Immune Response BioPharma, Clene Nanomedicine, Genzyme, ImStem Biotechnology, Bristol-Myers Squibb, TG Therapeutics, Hoffmann-La Roche, Atara Biotherapeutics ...

In a 2024 study from Iran, researchers examined the prevalence of antibodies that suggest autoimmune thyroid disease in 73 people newly diagnosed with MS and 72 without MS. They found increased ...

"Regions in the north and northeast of France have higher MS prevalence, and they also have a higher prevalence of lifestyle-related cancer risk factors, such as smoking and alcohol drinking.

Multiple Sclerosis companies are Immune Response BioPharma, Clene Nanomedicine, Genzyme, ImStem Biotechnology, Rho, Inc., Bristol-Myers Squibb, TG Therapeutics, Inc ...